» Articles » PMID: 36743024

Natural Bioactive Molecules As Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases

Overview
Journal ACS Omega
Specialty Chemistry
Date 2023 Feb 6
PMID 36743024
Authors
Affiliations
Soon will be listed here.
Abstract

The brain is vulnerable to different types of stresses, particularly oxidative stress as a result of oxygen requirements/utilization in the body. Large amounts of unsaturated fatty acids present in the brain increase this vulnerability. Neurodegenerative diseases (NDDs) are brain disorders that are characterized by the gradual loss of specific neurons and are attributed to broad evidence of cell-level oxidative stress. The accurate characterization of neurological disorders relies on several parameters along with genetics and environmental risk factors, making therapies less efficient to fight NDDs. On the way to tackle oxidative damage and discover efficient and safe therapies, bioactives are at the edge of NDD science. Naturally occurring bioactive compounds such as polyphenols, carotenoids, essential fatty acids, phytosterols, essential oils, etc. are particularly of interest owing to their potent antioxidant and anti-inflammatory activities, and they offer lots of brain-health-promoting features. This Review focuses on probing the neuroefficacy and bioefficacy of bioactives and their role in supporting relatively low antioxidative and low regenerative capacities of the brain, neurogenesis, neuroprotection, and ameliorating/treating NDDs.

Citing Articles

From Molecules to Mind: The Critical Role of Chitosan, Collagen, Alginate, and Other Biopolymers in Neuroprotection and Neurodegeneration.

Kruczkowska W, Galeziewska J, Grabowska K, Gromek P, Czajkowska K, Rybicki M Molecules. 2025; 30(5).

PMID: 40076240 PMC: 11901451. DOI: 10.3390/molecules30051017.


Neurotherapeutic impact of vanillic acid and ibudilast on the cuprizone model of multiple sclerosis.

Alderbi R, Alam M, Alghamdi B, Alsufiani H, Abd El-Aziz G, Omar U Front Mol Neurosci. 2025; 17:1503396.

PMID: 39866908 PMC: 11760597. DOI: 10.3389/fnmol.2024.1503396.


Phytosome-Encapsulated 6-Gingerol- and 6-Shogaol-Enriched Extracts from Roscoe Protect Against Oxidative Stress-Induced Neurotoxicity.

Mairuae N, Noisa P, Palachai N Molecules. 2025; 29(24.

PMID: 39770133 PMC: 11677370. DOI: 10.3390/molecules29246046.


Nutritional Benefits of Lycopene and Beta-Carotene: A Comprehensive Overview.

Tufail T, Ul Ain H, Noreen S, Ikram A, Arshad M, Abdullahi M Food Sci Nutr. 2024; 12(11):8715-8741.

PMID: 39619948 PMC: 11606860. DOI: 10.1002/fsn3.4502.


New Perspectives on the Old Uses of Traditional Medicinal and Edible Herbs: Extract and Spent Material of (L.) Delarbre.

Jovanovic M, Vunduk J, Mitic-Culafic D, Svircev E, Vojvodic P, Tomic N Nutrients. 2024; 16(19).

PMID: 39408335 PMC: 11478433. DOI: 10.3390/nu16193368.


References
1.
Rahaiee S, Assadpour E, Faridi Esfanjani A, Sanches Silva A, Jafari S . Application of nano/microencapsulated phenolic compounds against cancer. Adv Colloid Interface Sci. 2020; 279:102153. DOI: 10.1016/j.cis.2020.102153. View

2.
Morris M, Evans D, Tangney C, Bienias J, Wilson R, Aggarwal N . Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change. Am J Clin Nutr. 2005; 81(2):508-14. DOI: 10.1093/ajcn.81.2.508. View

3.
Wang J, Zhang Y, Tang L, Zhang N, Fan D . Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci Lett. 2011; 503(3):250-5. DOI: 10.1016/j.neulet.2011.08.047. View

4.
Ajiboye B, Ojo O, Okesola M, Akinyemi A, Talabi J, Idowu O . In vitro antioxidant activities and inhibitory effects of phenolic extract of (Oliv and Hiern) against key enzymes linked with type II diabetes mellitus and Alzheimer's disease. Food Sci Nutr. 2018; 6(7):1803-1810. PMC: 6189626. DOI: 10.1002/fsn3.749. View

5.
Prakash A, Kumar A . Implicating the role of lycopene in restoration of mitochondrial enzymes and BDNF levels in β-amyloid induced Alzheimer׳s disease. Eur J Pharmacol. 2014; 741:104-11. DOI: 10.1016/j.ejphar.2014.07.036. View